Literature DB >> 21499112

Predictors of CD4 eligibility for antiretroviral therapy initiation among HIV-infected pregnant women in Lusaka, Zambia.

Katherine C Liu1, Jessica Mulindwa, Mark J Giganti, Nande B Putta, Namwinga Chintu, Benjamin H Chi, Jeffrey S A Stringer, Elizabeth M Stringer.   

Abstract

BACKGROUND: In resource-limited settings, CD4 testing is a barrier to antiretroviral therapy initiation in pregnancy.
METHODS: We used logistic regression to identify predictors of CD4 cell count ≤ 350 cells/uL in 20,233 pregnant women.
RESULTS: The best-performing model included any 3 of: age ≥ 28 years old, hemoglobin ≤ 9.8 g/dL, gestational age ≤ 30 weeks, weight ≤ 64 kg, history of tuberculosis or previous death of an infant prior to one year old. Sensitivity was 45.7% (95% CI: 44.5-47.0), specificity 70.7% (95% CI: 69.6-71.8), and misclassification rate 41.4% (95% CI: 40.5-42.2).
CONCLUSION: CD4 triage remains a critical element of maternal HIV care and PMTCT.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21499112      PMCID: PMC3159712          DOI: 10.1097/QAI.0b013e31821d3507

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  22 in total

1.  Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania.

Authors:  Megan E O'Brien; Roland Kupka; Gernard I Msamanga; Elmar Saathoff; David J Hunter; Wafaie W Fawzi
Journal:  J Acquir Immune Defic Syndr       Date:  2005-10-01       Impact factor: 3.731

Review 2.  Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Authors:  Amy S Sturt; Emily Kainne Dokubo; Tin Tin Sint
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

Review 3.  Challenges in implementing CD4 testing in resource-limited settings.

Authors:  Trevor Peter; Anne Badrichani; Emily Wu; Richard Freeman; Bekezela Ncube; Fabiana Ariki; Jennifer Daily; Yoko Shimada; Maurine Murtagh
Journal:  Cytometry B Clin Cytom       Date:  2008       Impact factor: 3.058

4.  Effects of early, abrupt weaning on HIV-free survival of children in Zambia.

Authors:  Louise Kuhn; Grace M Aldrovandi; Moses Sinkala; Chipepo Kankasa; Katherine Semrau; Mwiya Mwiya; Prisca Kasonde; Nancy Scott; Cheswa Vwalika; Jan Walter; Marc Bulterys; Wei-Yann Tsai; Donald M Thea
Journal:  N Engl J Med       Date:  2008-06-04       Impact factor: 91.245

5.  Comparison of CD4 cell count, viral load, and other markers for the prediction of mortality among HIV-1-infected Kenyan pregnant women.

Authors:  Elizabeth R Brown; Phelgona Otieno; Dorothy A Mbori-Ngacha; Carey Farquhar; Elizabeth M Obimbo; Ruth Nduati; Julie Overbaugh; Grace C John-Stewart
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

6.  Screening HIV-positive pregnant women for antiretroviral therapy: utility of self-reported symptoms.

Authors:  Ruby Hn Nguyen; Stephen J Gange; David Serwadda; Godfrey Kigozi; Noah Kiwanuka; Nelson K Sewankambo; Fred Wabwire-Mangen; Thomas C Quinn; Maria Wawer; Ronald H Gray
Journal:  Int J STD AIDS       Date:  2006-02       Impact factor: 1.359

7.  Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.

Authors:  Didier K Ekouevi; Patrick A Coffie; Renaud Becquet; Besigin Tonwe-Gold; Appolinaire Horo; Rodolphe Thiebaut; Valériane Leroy; Stéphane Blanche; François Dabis; Elaine J Abrams
Journal:  AIDS       Date:  2008-09-12       Impact factor: 4.177

8.  Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa.

Authors:  Isaac M Kigozi; Loren M Dobkin; Jeffrey N Martin; Elvin H Geng; Winnie Muyindike; Nneka I Emenyonu; David R Bangsberg; Judith A Hahn
Journal:  J Acquir Immune Defic Syndr       Date:  2009-10-01       Impact factor: 3.731

9.  Differential effects of early weaning for HIV-free survival of children born to HIV-infected mothers by severity of maternal disease.

Authors:  Louise Kuhn; Grace M Aldrovandi; Moses Sinkala; Chipepo Kankasa; Katherine Semrau; Prisca Kasonde; Mwiya Mwiya; Wei-Yann Tsai; Donald M Thea
Journal:  PLoS One       Date:  2009-06-26       Impact factor: 3.240

10.  Prevention of mother-to-child transmission of HIV in Zambia: implementing efficacious ARV regimens in primary health centers.

Authors:  Justin Mandala; Kwasi Torpey; Prisca Kasonde; Mushota Kabaso; Rebecca Dirks; Chiho Suzuki; Catherine Thompson; Gloria Sangiwa; Ya Diul Mukadi
Journal:  BMC Public Health       Date:  2009-08-27       Impact factor: 3.295

View more
  5 in total

1.  Nonvirologic algorithms for predicting HIV infection among HIV-exposed infants younger than 12 weeks of age.

Authors:  Benjamin H Chi; Mohammed I Limbada; Mark J Giganti; Michelle S Li; Maximillian Bweupe; Patrick Musonda; Peggy Bubala; Mwangelwa Mubiana-Mbewe; Namwinga T Chintu; Carolyn Bolton-Moore; Jeffrey S A Stringer
Journal:  Pediatr Infect Dis J       Date:  2013-02       Impact factor: 2.129

2.  Impact of expanded access to combination antiretroviral therapy in pregnancy: results from a cohort study in Ukraine.

Authors:  Heather Bailey; Claire L Townsend; Igor Semenenko; Ruslan Malyuta; Mario Cortina-Borja; Claire Thorne
Journal:  Bull World Health Organ       Date:  2013-04-24       Impact factor: 9.408

Review 3.  Underutilisation of routinely collected data in the HIV programme in Zambia: a review of quantitatively analysed peer-reviewed articles.

Authors:  Tendai Munthali; Patrick Musonda; Paul Mee; Sehlulekile Gumede; Ab Schaap; Alwyn Mwinga; Caroline Phiri; Nathan Kapata; Charles Michelo; Jim Todd
Journal:  Health Res Policy Syst       Date:  2017-06-13

4.  Mortality and health outcomes of HIV-exposed and unexposed children in a PMTCT cohort in Malawi.

Authors:  Megan Landes; Monique van Lettow; Adrienne K Chan; Isabell Mayuni; Erik J Schouten; Richard A Bedell
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

5.  Screening HIV-infected adults in Malawi for anaemia: impact on eligibility for antiretroviral therapy.

Authors:  I D Page; S J McKew; A G Kudzala; C Fullwood; J J van Oosterhout; I Bates
Journal:  Int J STD AIDS       Date:  2013-06-18       Impact factor: 1.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.